STRIDES PHARMA SCI LTD (STAR) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products.[1]The company's pharmaceutical products are sold in over 100 countries.[2]The company has always followed an inorganic growth strategy over the years that resulted in foray into new markets, a…

STARUpdated 1 Sept 2026, 12:03

Strides Pharma Sci Ltd

Market Cap

₹9,397Cr.

Current Price

₹1,019

High / Low

₹1,231/769

Stock P/E

52.2

ROE2.27%
ROCE4.88%
Book Value₹356
Face Value₹10.0
Dividend Yield0.49%

About

Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products.[1]The company's pharmaceutical products are sold in over 100 countries.[2]The company has always followed an inorganic growth strategy over the years that resulted in foray into new markets, addition of new business segments, therapy segments and manufacturing infrastructure.[3]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days101117143112138141161239257306248255
Inventory Days110113204126197189254170168188145191
Days Payable133148234183212200271213220205163225
Cash Conversion Cycle778211255123130144196205289230220
Working Capital Days3328-611-14-37162248418383
ROCE %9%6%5%24%4%5%4%2%2%2%5%5%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 12:03


Designed & Shipped by Harshit Bansal